<?xml version="1.0" encoding="UTF-8"?>
<p>In this scenario of reemergence of outbreaks, there is a concern about the intensity of the disease in the acute phase, which may cause incapacity, and the risk of complications in users of immunosuppressive drugs, especially patients with rheumatological disease who already have joint involvement [
 <xref rid="B8" ref-type="bibr">8</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>].
</p>
